Global General Anesthesia Drugs market Size by Type, End User and Application: Global
Opportunity Analysis and Industry Forecast, 2020-2025. The base year considered for the study is
2020, and the forecast has been provided for the period from 2020 to 2025.
General anesthetics are drugs that have the ability to bring about a reversible loss of consciousness.
Anesthetists administer these drugs to induce or maintain general anaesthesia to facilitate surgery.
Some of these drugs are also used in lower dosages for pain management.
General Anesthesia Drugs can be divided into two categories, Intravenous Anesthetics, accounting
for 69.62% and Inhalational Anesthetics, accounting for 30.38%. Intravenous Anesthetics widely
used drugs are: Propofol, Etomidate, Midazolam, Barbiturates (such as thiopental), and so on.
Desflurane, Isoflurane and Sevoflurane are the most widely used Inhalational Anesthetics. Propofol
hold the largest market share of General Anesthesia Drugs with 33.83% market share. Sevoflurane
market share is over 21.17%, being the second largest market share of General Anesthesia Drugs.
Europe is the largest supplier and consumption market of General Anesthesia Drugs, with a
production market share of nearly 38% and sales market share nearly 32%. The second place is
USA, following Europe with the production market share of 20% and the sales market share over
28%. Asia is another important market of General Anesthesia Drugs, enjoying 24% production
market share and 25% sales market share.
According to this study General Anesthesia Drugs market will register a 3.9% CAGR in terms of
revenue, the global market size will reach US$ 8170 million by 2025, from US$ 6500 million in
The research report offers an outlook of the attractiveness of the segments and regions, which are
formulated based on their growth rate (CAGR) and market size. General Anesthesia Drugs market
cost investigation has been performed while keeping in producing costs, overview work cost, and